Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT01708161 |
| Title | A Phase Ib/II Study of the Combination of BYL719 Plus AMG 479 in Adult Patients With Selected Solid Tumors |
| Recruitment | Terminated |
| Gender | both |
| Phase | Phase I |
| Variant Requirements | Yes |
| Sponsors | Novartis|Novartis Pharmaceuticals|Amgen |
| Indications | |
| Therapies | |
| Age Groups: | adult |
| Covered Countries | USA | ESP | CAN | BEL |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| Novartis Investigative Site | Los Angeles | California | 90095 | United States | Details | |
| Novartis Investigative Site | Boston | Massachusetts | 02114 | United States | Details | |
| Novartis Investigative Site | New York | New York | 10017 | United States | Details | |
| Novartis Investigative Site | Nashville | Tennessee | 37203 | United States | Details | |
| Novartis Investigative Site | Leuven | 3000 | Belgium | Details | ||
| Novartis Investigative Site | Toronto | Ontario | M5G 1Z6 | Canada | Details | |
| Novartis Investigative Site | Sevilla | Andalucia | 41013 | Spain | Details | |
| Novartis Investigative Site | Barcelona | Catalunya | 08035 | Spain | Details | |
| Novartis Investigative Site | Madrid | 28033 | Spain | Details | ||
| Novartis Investigative Site | Madrid | 28041 | Spain | Details |